Trial intelligence / Profile preview

Comparative effect of two doses of mannitol on post-traumatic intracranial hypertension

2008-004979-21Phase 4Active

Sponsor
CHU Grenoble Alpes
Start
Sep 2008
Modality
Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised trial of Bronchitol in intracranial hypertension (IH) (2 arms), sponsored by CHU Grenoble Alpes. Primary endpoint: Primary intracranial pressure response. Started Sep 2008; status: active.

02

Drugs

Bronchitol
03

Conditions

intracranial hypertension (IH)

Beyond the preview

Go deeper on 2008-004979-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-004979-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call